https://www.selleckchem.com/products/ko143.html
As the most common primary intracranial tumor, glioblastoma (GBM) is a malignant tumor that originated from neuroepithelial tissue, accounting for 40-50% of brain tumors. Precise survival prediction for patients suffering from GBM can not only help patients and doctors formulate treatment plans, but also help researchers understand the development of the disease and stimulate medical development. In view of the tedious process of manual feature extraction and selection in traditional radiomics, we propose an end-to-end survival prediction
Like
Comment
Share
